• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Tags Pharmaceutical Industry

    Tag: Pharmaceutical Industry

    Drug firms argue against $1.2B Arkansas judgment
    Business

    Drug firms argue against $1.2B Arkansas judgment

    Washington Examiner -
    February 27, 2014 4:59 pm
    0
    New drug shortages declined in 2012 for the first time in a number of years and 2013 data indicated a similar downward trend. (Photo: Thinkstock)
    Healthcare

    FDA’s plan to ease drug shortages needs work

    Peter Pitts -
    February 27, 2014 5:00 am
    0
    Pfizer and Chesapeake are big market movers
    Business

    Pfizer and Chesapeake are big market movers

    Washington Examiner -
    February 24, 2014 9:39 pm
    0
    Endo Pharmaceuticals paying $172M False Claims Act settlement over Lidoderm patch

    Endo Pharmaceuticals paying $172M False Claims Act settlement over Lidoderm patch

    Jon Campisi -
    February 24, 2014 9:25 pm
    0
    New York AG follows with settlement with Ranbaxy, Teva

    New York AG follows with settlement with Ranbaxy, Teva

    Bryan Cohen -
    February 21, 2014 8:53 pm
    0
    Bayer clotting drug meets late-stage study’s goal
    Business

    Bayer clotting drug meets late-stage study’s goal

    Linda Johnson -
    February 18, 2014 11:12 pm
    0
    Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B
    Business

    Actavis to buy fellow drugmaker Forest Laboratories in cash-and-stock deal worth about $25B

    Washington Examiner -
    February 18, 2014 12:04 pm
    0
    Medications containing pseudoephedrine are on display. The West Virginia Senate is scheduled to vote on a bill to make drugs used in the production of methamphetamine available only by prescription. (AP/Sue Ogrocki)
    Healthcare

    Many cold meds could go prescription-only as West Virginia aims to block meth-making

    Associated Press -
    February 18, 2014 5:00 am
    0
    FDA rejects wider use of J&J Xarelto for 3rd time
    Business

    FDA rejects wider use of J&J Xarelto for 3rd time

    Washington Examiner -
    February 14, 2014 5:46 pm
    0
    FILE - In this Tuesday, Dec. 21, 2004, file photo, several Aleve tablets appear in front of bottles of the pain reliever, in Boston.  Federal health experts are taking a second look this week at the heart safety of pain medications used by millions of Americans to treat arthritis and other everyday aches and pains. (AP Photo/Steven Senne, File)
    Business

    FDA reconsiders heart safety of common pain pills

    Matthew Perrone -
    February 10, 2014 9:36 pm
    0
    1...150151152153Page 151 of 153
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter